NEWMAN MARY

CIK 00016791321 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001679132

Recent Transactions

23 trades

Award
Audentes Therapeutics, Inc.
Common Stock
2018-11-15$19.64/sh+660→ 660 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-06-25$41.37/sh−300→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-06-25$40.77/sh−8,245→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-06-25$2.19/sh+300→ 300 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-06-25$2.19/sh+8,245→ 8,245 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-06-25−8,545→ 15,272 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-03-15−10,000→ 23,817 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$29.66/sh−4,076→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$30.79/sh−5,524→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$2.19/sh+5,524→ 5,524 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$2.19/sh+400→ 400 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$31.62/sh−400→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-03-15$2.19/sh+4,076→ 4,076 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-11-16+50,000→ 50,000 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2017-11-16$2.19/sh+4,260→ 4,260 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-11-16−10,000→ 33,817 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2017-11-16$27.31/sh−4,260→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2017-11-16$2.19/sh+5,740→ 5,740 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2017-11-16$26.49/sh−5,740→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2017-08-24$2.19/sh+10,000→ 10,000 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-08-24−10,000→ 43,817 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2017-08-24$20.00/sh−10,000→ 0 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-01-25+50,000→ 50,000 total

Companies

Audentes Therapeutics, Inc.
SVP, Regulatory Affairs

Recent Filings

Address

C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR

SAN FRANCISCO, CA, 94108

View on SEC.gov